SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies
Clinical trial NCT04684108 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04684108
- Sponsor
- Hangzhou Sumgen Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-04
- Primary completion
- 2024-06-30
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.